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SUMMARY
Primary cutaneous lymphomas (PCLs) are exceedingly rare
in children and adolescents, with mycosis fungoides (MF)
being the most frequent PCL diagnosed in childhood.
There are numerous unusual clinical variants of MF,
including the hypopigmented type form (HMF). HMF is
exceptional overall, but comparatively common among
children. We present an 8-year-old boy with a 3-year
history of progressive, generalised, scaly, hypopigmented
round patches and few erythematous papules. He was
ﬁrst diagnosed with pityriasis alba (PA), and moisturisers
were prescribed with no improvement. Skin biopsy
showed typical features of MF, and the patient was
successfully treated with narrowband ultraviolet B. HMF
may simulate atopic dermatitis, PA, pityriasis lichenoides,
tinea versicolour, vitiligo, postinﬂammatory
hypopigmentation or leprosy. Therefore, persistent and
unusual hypopigmented lesions should be biopsied to
rule out this rare variant of MF.
BACKGROUND
Mycosis fungoides (MF) is the most common
primary cutaneous lymphoma in children.
Hypopigmented mycosis fungoides (HMF) is an
extremely rare variant. HMF is usually observed in
dark-skinned individuals, comparatively common
among children, and often shows a T-suppressor
CD8+phenotype.1–3 The diagnosis of MF in child-
hood is commonly delayed, since it can show clin-
ical as well as histological resemblances to benign
inﬂammatory disorders. Few studies have reviewed
MF in childhood, however, the hypopigmented
variant is probably associated with better prognosis
than classic MF.1 4 5 In the presented case, diagno-
sis was made 3 years after the onset of the derma-
tosis. This case illustrates the importance of clinical
suspicion for MF in patients with hypopigmented
lesions, particularly in children.
CASE PRESENTATION
We present an 8-year-old Caucasian boy with a
3-year history of progressive, generalised, scaly
hypopigmented round patches, 2–5 cm in diameter,
associated with few erythematous papules, with
normal overlying skin (ﬁgures 1 and 2). The boy
was otherwise healthy, with no signs of atopy
(namely xerosis, periorbital darkening or
Dennie-Morgan infraorbital fold), and had no
family history of atopy, other inﬂammatory derma-
tosis or signiﬁcant environmental exposure. He was
skin phototype III. He was initially diagnosed with
pityriasis alba and, during the 3 symptomatic years,
prescribed moisturisers. However, during this
period he showed no improvement and new hypo-
pigmented lesions appeared continuously.
INVESTIGATIONS
A punch biopsy from a hypopigmented patch
showed typical features of MF (lymphocytic inﬁl-
tration in the upper and mid-dermis with mild
atypia and epidermotropism of single and clustered
lymphocytes; ﬁgure 3). Most lymphoid skin cells
were CD8+/CD3+(49%), the γδ-T-cell subpopula-
tion was increased (18%) and T-cell receptor
rearrangement analysis did not show clonal T-cell
population. The patient had no lymphadenopathy
or organomegaly; renal, hepatic function and com-
plete blood count with differential were within
normal limits; chest X-ray and abdominal ultra-
sound were likewise normal. The patient was diag-
nosed with HMF, stage Ib (T2N0M0B0).
DIFFERENTIAL DIAGNOSIS
Pityriasis alba (PA), a very common disease, was
considered the most likely diagnosis during the ﬁrst
clinical observations, when the patient presented
fewer hypopigmented lesions. However, generalised
lesions and poor response to moisturisers, in a
patient with no history of atopy, do not support
the PA diagnosis. Additionally, in PA, the hypopig-
mented lesions are generally conﬁned to the face,
neck and upper arms.6
Other diagnoses considered were vitiligo and pityr-
iasis lichenoides (PL). Vitiligo is characterised by
totally amelanotic lesions, with typical convex
borders. This patient did not show truly depigmen-
tated lesions, and the lesions spared the face and geni-
tals, which is not a suggestive distribution for vitiligo.
Figure 1 Patient presentation: generalised hypopigmented
round patches 2–5 cm in diameter, slightly scaly.
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Pitiryasis lichenoides et varioliformis acuta (PLEVA) and pytir-
iasis lichenoides chronica (PLC) represent two ends of a disease
spectrum that mostly affect young patients. PLEVA generally
presents as recurrent crops of ulcerative papulonodules, lasting
for weeks and PLC is characterised by recurrent crops of red-
brown scaly papules that can persist for months; all forms of PL
can result in postinﬂammatory hypopigmentation or hyperpig-
mentation. Histologically, the typical features of PL are paraker-
atosis, lymphocytic inﬁltrate, exocytosis, spongiosis and red
blood cell extravasation. In the presented case, the patient had a
continuous progressive course, the progression of erythematous
papules to hypopigmented lesions was not observed and there
were none of the histological features usually associated with PL
or with posthypopigmented inﬂammation.3 7 Although not a
common feature of MF, erythematous papules were already
described particularly in HMF.8
TREATMENT
The patient was treated with narrowband ultraviolet B (UVB)
phototherapy sessions, 3 times weekly, achieving complete clin-
ical response, after a cumulative dose of 41.7 J/cm2 in 30 ses-
sions (ﬁgure 4).
OUTCOME AND FOLLOW-UP
The patient experienced no recurrence of the disease 10 months
after discontinuation of phototherapy.
DISCUSSION
MF is the most common primary cutaneous lymphoma (PCL).
It is mainly a disease of the elderly, generally in the ﬁfth and
sixth decades of life, and exhibits a slight male predominance.9
MF is classiﬁed as an indolent lymphoma according to
WHO-EORTC PCL classiﬁcation.10 The cutaneous expression
of MF consists of four basic patterns: an early patch stage with
eczematous features; a plaque stage; a tumour stage; and an ery-
throdermic stage. Progression to tumoural lesions generally
occurs several years after onset of the disease.9
Zackheim and McCalmont11 referred to MF as ‘the great imita-
tor’—a description previously reserved for syphilis. Diagnosis is
frequently difﬁcult, since numerous clinical variants of MF are
described, including granulomatous, pustular, bullous, hyperkera-
totic and verrucous forms. Moreover, the differential diagnosis
includes several benign skin disorders such as eczema, psoriasis
and contact dermatitis. The presenting colour varies from pink to
orange, to a dusky violet red, brownish and, more rarely, hypopig-
mented.4 The latter is mainly observed in Asians and dark-skinned
individuals, and is generally diagnosed at a younger age than
classic MF.4 12–14 Our patient showed hypopigmented lesions
associated with few erythematous papules. It was previously sug-
gested that this clinical presentation of HMF might be predomin-
antly observed in Caucasian patients; alternatively, erythematous
lesions can be difﬁcult to identify in higher phototypes.8
MF may seldom arise in children and young adults, and
although HMF is an extremely rare variant, it is comparatively
common among children diagnosed with MF.1–3 Clinically,
HMF may mimic benign skin diseases for which diagnosis is
generally supported only by clinical features, including vitiligo,
tinea versicolour, PA, PLC or postinﬂammatory hypopigmenta-
tion.8 In the presented case, the lesions were initially misinter-
preted as PA, and diagnosis was delayed by 3 years. MF in
childhood is likely to be underestimated.
Contrary to classic MF in the early patch stage, HMF gener-
ally shows prominent epidermotropism and minimal dermal
involvement or ﬁbroplasia of the reticular dermis,1 12 as we
observed in our patient. Furthermore, unlike classic MF, which
characteristically presents with a CD4+phenotype, HMF often
displays a T-suppressor CD8+phenotype.1 15 In our patient,
there was no evidence of a monoclonal gene rearrangement in
the lymphocytic population; however, an inverted CD4/CD8
ratio was observed, suggesting that the neoplastic population
was CD8+. Although the presence of T-cell clonality supports
the diagnosis of MF, the absence of clonality should not be a cri-
terion to rule out the diagnosis.8
Figure 4 Complete clinical response after 30 sessions of narrowband
ultraviolet B phototherapy. The cumulative dose was 41.7 J/cm2.
Figure 3 Dermatopathology: parakeratosis and acanthosis,
lymphocytic inﬁltrate in the superﬁcial dermis, lymphocytes presenting
moderate atypia and epidermotropism, occasionally resembling
Pautrier’s microabscesses.
Figure 2 Patient presentation: generalised hypopigmented round
patches 2–5 cm in diameter, slightly scaly, with no inﬁltration.
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Treatment modalities for HMF include topical corticosteroids
alone or in combination with narrow band UVB, or psoralen
and UVA. There are no established protocols for the treatment
of MF in children; phototherapy offers an effective option for
the treatment of HMF, but recurrences are common.16 17 In the
largest retrospective study on paediatric HMF, 45.7% (16/35) of
patients improved with phototherapy; however, 20% of these
recurred, and only 7% (5/35) had a complete response. In the
same study, one patient progressed to tumour stage.9 Likewise,
in a small cohort of hypopigmented MF (mean age at diagnosis
34.4 years), recurrence was observed in 8 of 9 patients after
phototherapy, and none of the patients progressed beyond stage
1 disease.4 Agar et al reported on the overall survival (OS),
disease-speciﬁc survival (DSS) and risk of disease progression
(RDP) of patients with MF and Sézary syndrome from a cohort
of 1502 patients. They observed that the hypopigmented
variant had an OS and DSS of 98% at 20 years, with RDP of
9% at 20 years, which was signiﬁcantly better than classic MF.15
These ﬁndings support the hypothesis that HMF may have a
better course than classic MF.1 5 Few studies have reviewed MF
in childhood, and we believe that additional data are necessary
to better assess prognosis and outcome in this subset of patients.
Early classic MF is characterised by a predominantly
Th1-type immune response. Evolution from patches to plaques
and tumours accompanies a shift from Th1 to Th2 response.
In HMF, the CD8+T-cells participate in the Th1 immune
response, and thus may prevent evolution to aggressive stages,
even though the cells are malignant. In cases of patients with
HMF with a CD4+neoplastic inﬁltrate, CD8+T cells may also
have an important immunoregulatory action.18 Moreover, CD8
+phenotype predominance is consistent with the hypothesis
that hypopigmentation results from lymphocyte cytotoxicity
against melanocytes and melanogenesis, as observed in vitiligo
pathogenesis.8 18 Therefore, hypopigmentation might represent
the clinical translation of the protective immune response, and a
marker of good prognosis.
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Learning points
▸ Mycosis fungoides (MF) is the most common primary
cutaneous lymphoma in children.
▸ Hypopigmented mycosis fungoides (HMF) is an extremely
rare variant, but relatively common in childhood.
▸ HMF is more frequently observed in dark-skinned individuals
and, contrary to classic MF, usually presents a CD8
+phenotype.
▸ HMF can be efﬁciently treated with phototherapy, but
recurrence rates are high.
▸ HMF is associated with a better prognosis than classic MF,
and hypopigmentation may represent the clinical translation
of the protective immune response associated with a CD8
+phenotype.
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